ArticleJournal of surgery and science2014
The role of HER-2 in Breast Cancer.
Abstract read
In one paragraph
Article in Journal of surgery and science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Addressing the Challenges in the Identification of HER2-Low and Ultralow Breast Cancer in Asia: A Delphi Consensus.Advances in therapy · 2026Article
- Nanoparticles Targeting the Tumor Microenvironment for the Treatment of Osteosarcoma: Recent Progress and Perspectives.International journal of nanomedicine · 2026Review
- Nanotechnology Platform for the Delivery of Docetaxel and Tyrosine Kinase Inhibitors for HER2-Positive Breast Cancer Therapy.Pharmaceutical nanotechnology · 2025Article
- Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind Study.Oncology and therapy · 2024Article
- Newly synthesized chitosan nanoparticles loaded with caffeine/moringa leaf extracts Halt Her2, BRCA1, and BRCA2 expressions.Scientific reports · 2024Article
- Rapid differentiation of estrogen receptor status in patient biopsy breast cancer aspirates with an optical nanosensor.bioRxiv : the preprint server for biology · 2024Article
- Diagnostic Accuracy of Immunohistochemistry for HER2-Positive Breast Cancer.Asian Pacific journal of cancer prevention : APJCP · 2023Article
- Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics.Nanomaterials (Basel, Switzerland) · 2023Review
- Evaluation of the Anti-Metastatic Effect of Foeniculum Vulgare on the Protein Expression of HSP 70 & 90 in Balb/c Mice with 4t1 Model of Breast Cancer.Asian Pacific journal of cancer prevention : APJCP · 2023Article
- A review of prognostic and predictive biomarkers in breast cancer.Clinical and experimental medicine · 2023Review
- Feline Oncogenomics: What Do We Know about the Genetics of Cancer in Domestic Cats?Veterinary sciences · 2022Review
- The Evolution of Molecular Recognition: From Antibodies to Molecularly Imprinted Polymers (MIPs) as Artificial Counterpart.Journal of functional biomaterials · 2022Review
- Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor.Frontiers in oncology · 2022Article
- Trans-(-)-Kusunokinin: A Potential Anticancer Lignan Compound against HER2 in Breast Cancer Cell Lines?Molecules (Basel, Switzerland) · 2021Article
- Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.International journal of molecular sciences · 2021Review
- Embracing Mechanobiology in Next Generation Organ-On-A-Chip Models of Bone Metastasis.Frontiers in medical technology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Takashi IshikawaDepartment of Breast Surgery, Tokyo Medical University ( ); Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan ( ); Department of Gastrointestinal Surgery and Department of Clinical Oncology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ( ), Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan ( ); Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA, USA ( ).
Yasushi IchikawaDepartment of Breast Surgery, Tokyo Medical University ( ); Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan ( ); Department of Gastrointestinal Surgery and Department of Clinical Oncology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ( ), Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan ( ); Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA, USA ( ).
Daisuke ShimizuDepartment of Breast Surgery, Tokyo Medical University ( ); Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan ( ); Department of Gastrointestinal Surgery and Department of Clinical Oncology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ( ), Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan ( ); Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA, USA ( ).
Takeshi SasakiDepartment of Breast Surgery, Tokyo Medical University ( ); Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan ( ); Department of Gastrointestinal Surgery and Department of Clinical Oncology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ( ), Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan ( ); Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA, USA ( ).
Mikiko TanabeDepartment of Breast Surgery, Tokyo Medical University ( ); Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan ( ); Department of Gastrointestinal Surgery and Department of Clinical Oncology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ( ), Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan ( ); Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA, USA ( ).
Takashi ChishimaDepartment of Breast Surgery, Tokyo Medical University ( ); Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan ( ); Department of Gastrointestinal Surgery and Department of Clinical Oncology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ( ), Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan ( ); Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA, USA ( ).
Kazuaki TakabeDepartment of Breast Surgery, Tokyo Medical University ( ); Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan ( ); Department of Gastrointestinal Surgery and Department of Clinical Oncology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ( ), Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan ( ); Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA, USA ( ).
Itaru EndoDepartment of Breast Surgery, Tokyo Medical University ( ); Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan ( ); Department of Gastrointestinal Surgery and Department of Clinical Oncology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ( ), Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan ( ); Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA, USA ( ).
Funding
Sphingosine-1 Phosphate in Breast Cancer Progression and LymphangiogenesisR01CA160688 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI TAKABE, KAZUAKI · 2012 to 2016
$1.5MNCI NIH HHS R01 CA160688
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
25679012PMC
PMC4323095What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.